Spinal Inhibitory Interneuron Pathology Follows Motor Neuron Degeneration Independent of Glial Mutant Superoxide Dismutase 1 Expression in SOD1-ALS Mice

Autor: Elize D. Haasdijk, Vera van Dis, Sebastian Cardona Cano, Casper C. Hoogenraad, Jan C. Holstege, Dick Jaarsma, Mehdi Hossaini
Přispěvatelé: Neurosciences
Rok vydání: 2011
Předmět:
Calbindins
Pathology
Proto-Oncogene Proteins c-jun
Galectin 3
Mice
Glycine Plasma Membrane Transport Proteins
Amyotrophic lateral sclerosis
Motor Neurons
Denervation
biology
Glutamate Decarboxylase
Age Factors
General Medicine
Parvalbumins
medicine.anatomical_structure
Spinal Cord
Neurology
Neuroglia
medicine.medical_specialty
Interneuron
Green Fluorescent Proteins
SOD1
Mice
Transgenic

Inhibitory postsynaptic potential
Choline O-Acetyltransferase
Pathology and Forensic Medicine
Cellular and Molecular Neuroscience
S100 Calcium Binding Protein G
Interneurons
medicine
Animals
Humans
RNA
Messenger

Activating Transcription Factor 3
Superoxide Dismutase
Ubiquitin
Amyotrophic Lateral Sclerosis
nutritional and metabolic diseases
medicine.disease
Spinal cord
Disease Models
Animal

Gene Expression Regulation
nervous system
Mutation
Nerve Degeneration
Glycine transporter 2
biology.protein
Neurology (clinical)
Neuron
Neuroscience
Zdroj: Journal of Neuropathology and Experimental Neurology, 70(8), 662-677. Oxford University Press
ISSN: 0022-3069
Popis: Motor neuron degeneration and skeletal muscle denervation are hallmarks of amyotrophic lateral sclerosis (ALS), but other neuron populations and glial cells are also involved in ALS pathogenesis. We examined changes in inhibitory interneurons in spinal cords of the ALS model low-copy Gurney G93A-SOD1 (G1del) mice and found reduced expression of markers of glycinergic and GABAergic neurons, that is, glycine transporter 2 (GlyT2) and glutamic acid decarboxylase (GAD65/67), specifically in the ventral horns of clinically affected mice. There was also loss of GlyT2 and GAD67 messenger RNA-labeled neurons in the intermediate zone. Ubiquitinated inclusions appeared in interneurons before 20 weeks of age, that is, after their development in motor neurons but before the onset of clinical signs and major motor neuron degeneration, which starts from 25 weeks of age. Because mutant superoxide dismutase 1 (SOD1) in glia might contribute to the pathogenesis, we also examined neuron-specific G93A-SOD1 mice; they also had loss of inhibitory interneuron markers in ventral horns and ubiquitinated interneuron inclusions. These data suggest that, in mutant SOD1-associated ALS, pathological changes may spread from motor neurons to interneurons in a relatively early phase of the disease, independent of the presence of mutant SOD1 in glia. The degeneration of spinal inhibitory interneurons may in turn facilitate degeneration of motor neurons and contribute to disease progression.
Databáze: OpenAIRE